iTrack Advance With iStent Infinite for Mild POAG

Show Description +

I. Paul Singh, MD, shares a case in which he combined iTrack Advance (Nova Eye Medical) with iStent Infinite (Glaukos) implantation in the eye of a pseudophakic patient with mild primary open-angle glaucoma who was taking three medications. The goal was to reduce medication burden but maintain IOP.

Financial disclosure: Consultant (Glaukos, Nova Eye Medical)

Posted: 4/15/2024

iTrack Advance With iStent Infinite for Mild POAG

I. Paul Singh, MD, shares a case in which he combined iTrack Advance (Nova Eye Medical) with iStent Infinite (Glaukos) implantation in the eye of a pseudophakic patient with mild primary open-angle glaucoma who was taking three medications. The goal was to reduce medication burden but maintain IOP.

Financial disclosure: Consultant (Glaukos, Nova Eye Medical)

Posted: 4/15/2024

Please log in to leave a comment.

More in Glaucoma

Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD